Skip to main content
This portal uses its own or third-party cookies for analytical purposes, as well as links to third-party portals in order to share content on social networks. You can get more information in the <a href="https://pro-assets-usc.azureedge.net/en/legal-notice">cookies policy</a>.
Molecular Medicine and Chronic Diseases Research Center (CIMUS)

INNOPHARMA's high-capacity infrastructures offer a set of services covering all stages of the drug discovery process, from target identification to preliminary safety and toxicity assessment. The platform is available for both on-demand services and complementary collaborative drug discovery projects.

The contents of this page were updated on 04.27.2023.